1. Home
  2. DLTR vs BNTX Comparison

DLTR vs BNTX Comparison

Compare DLTR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dollar Tree Inc.

DLTR

Dollar Tree Inc.

HOLD

Current Price

$93.83

Market Cap

20.9B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$99.16

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTR
BNTX
Founded
1986
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9B
24.2B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
DLTR
BNTX
Price
$93.83
$99.16
Analyst Decision
Hold
Strong Buy
Analyst Count
18
13
Target Price
$123.35
$133.46
AVG Volume (30 Days)
3.2M
798.0K
Earning Date
06-03-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
144.33
N/A
EPS
6.22
N/A
Revenue
$19,411,800,000.00
N/A
Revenue This Year
$8.48
N/A
Revenue Next Year
$5.90
$3.37
P/E Ratio
$15.20
N/A
Revenue Growth
10.43
N/A
52 Week Low
$83.11
$79.81
52 Week High
$142.40
$124.00

Technical Indicators

Market Signals
Indicator
DLTR
BNTX
Relative Strength Index (RSI) 33.59 49.81
Support Level $84.71 $99.08
Resistance Level $105.99 $113.05
Average True Range (ATR) 3.90 3.49
MACD -0.46 -0.54
Stochastic Oscillator 1.96 22.79

Price Performance

Historical Comparison
DLTR
BNTX

About DLTR Dollar Tree Inc.

Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2024, Dollar Tree generated over $17 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: